It was reported that transfection of GBP2 in colorectal cancer (CRC) cells inhibited their growth and increased their sensitivity to paclitaxel in a paclitaxel-resistant CRC, impairing Wnt signaling [54]. Here, GBP2 is linked to colorectal carcinoma.